24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500
Regular Business Hours: Monday - Friday 8am - 5pm
Every 3rd Thursday of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Half of Americans Still Not Wearing Masks When Out in Public: PollFor Maximum Effectiveness, De-Stress and Get Healthy Before Your COVID ShotUK Prime Minister Says British COVID Variant May Be More DeadlyImmune System May 'Remember' Infections From Previous CoronavirusesYou're More Likely to Maintain Social Distance If Your Friends Do: StudyExercise Doesn't Boost Health If You Stay Obese, Study FindsEven When Cancer Is in Remission, Patients' Risks of Severe COVID RiseFor Rising Number of People, Obesity Is a Literal HeadacheSevere Allergic Reaction Extremely Rare With Pfizer COVID Vaccine: StudyWill Vaccines Work Against the New Coronavirus Variants?More Than 200,000 Americans Have LupusKids Highly Likely to Transmit Coronavirus to Others: StudyArthritis Drug Tocilizumab Flops as COVID-19 TreatmentBiden Unveils Details of National Pandemic Response PlanDental Practices Rebound as U.S. Dentists Look Forward to COVID VaccineAHA News: COVID-19 Registries Offer Lessons Beyond the CoronavirusCOVID-19 Ups Complication Risks During ChildbirthWhen ICUs Near Capacity, COVID Patients' Risk for Death Nearly DoublesGetting the COVID Vaccine? A Good Night's Sleep Will HelpAmerica Sees COVID Deaths Top 400,000, While New Variants Worry ScientistsNasal Spray COVID Vaccine Shows Promise in Animal TrialsFried Food a Big Factor in Heart Disease, StrokePromising Steps Toward Retinal Cell Transplants to Fight BlindnessDo You Socially Distance? Your Income Might MatterIf a Nursing Home Resident Gets a COVID Shot, Can Their Families Visit Them Now?Vision Problems? Here's a Guide to Which Specialist Is Right for YouShould Your Child Get a COVID Test?New Hope Against Diseases Marked by Progressive Scarring of Lung TissueAHA News: What Heart and Stroke Patients Should Know About COVID-19 VaccinesCOVID Pandemic Shortened U.S. Life Expectancy by More Than a YearShorter COVID Quarantine for College Athletes a Good Idea, Study FindsWhat Happened to the Flu This Year?3 Steps Could Nearly Eliminate COVID Infections on College Campuses: StudyPharmacy Chains Ready to Supply COVID-19 Vaccines to AmericansI've Already Had COVID-19, Do I Need the Vaccine?What Will COVID-19 Look Like Years From Now?First Computer Model of Entire COVID Virus Will Aid ResearchStopping Common Heart Meds Could Be Risky for Kidney PatientsU.S. COVID Vaccine Rollout Nears 1 Million Doses Per DayJohnson & Johnson's One-Dose COVID Vaccine Promising in Early TrialLockdowns' Benefits for Air Quality Weren't as Big as Thought: StudyPeople's 'Microbiomes' Might Influence COVID-19 Severity: StudyNew Insights Into How COVID-19 Damages the BrainCollege Campuses Are COVID 'Superspreaders,' Study FindsStuck at Home, Suffering With COVID? Experts Offer Guidance on CareCOVID Daily Death Toll Sets New U.S. Record, Soars Past 4,400AHA News: Registries Could Offer Insight Into COVID-19's Impact on College Athletes' HeartsResearch Reveals Why COVID Pneumonia Is More DeadlyPandemic Is Tied to Big Rise in U.S. Heart DeathsCommon Diabetes Meds Tied to Serious COVID-19 Complication
Questions and AnswersLinks
Related Topics

Diabetes

Antibodies Fade a Few Weeks After Mild COVID-19, Study Finds

HealthDay News
by By E.J. Mundell
HealthDay Reporter
Updated: Jul 22nd 2020

new article illustration

WEDNESDAY, July 22, 2020 (HealthDay News) -- Hopes for robust, long-term antibody protection after a bout of COVID-19 have been dampened by a new study that finds the protection may only last a few months.

Still, experts noted that the body's immune system has more than one way to defend against viruses it has already encountered, so the findings don't dash hopes for a vaccine.

"Infection with this coronavirus does not necessarily generate lifetime immunity," Dr. Buddy Creech, an infectious disease specialist at Vanderbilt University in Nashville, told the Associated Press.

But antibodies are only part of the immune system's armamentarium, added Creech, who wasn't part of the new research.

The study was published July 21 in the New England Journal of Medicine. Researchers led by Dr. Otto Yang, of the University of California, Los Angeles, sought to determine the "half-life" of antibodies generated by contact with the new SARS-CoV-2 virus. Half-life means the time it takes for half of the antibodies to disappear.

Yang's group took blood samples from 34 people who had all recovered from a mild case of COVID-19. Twenty were women and 14 were men, and they averaged 43 years of age.

Based on blood tests collected up to 119 days after the onset of symptoms, the researchers said the half-life of antibodies linked with SARS-CoV-2 infection was just 36 days -- just over a month. At that rate, antibodies would disappear completely in about a year.

It's an "antibody loss [rate] that was quicker than that reported for SARS-CoV-1," the coronavirus responsible for the 2003 SARS outbreak, the researchers noted.

"Our findings raise concern that humoral [found in body fluids] immunity against SARS-CoV-2 may not be long lasting in persons with mild illness, who compose the majority of people with COVID-19," they said.

"Like the common cold-causing coronaviruses, the new coronavirus does not appear to provide durable antibody-based immunity for a long period of time," said Dr. Amesh Adalja, a senior scholar with the Johns Hopkins Center for Health Security in Baltimore.

But that doesn't mean that immunity necessarily is gone, he added, since the human immune system has other tricks up its sleeve.

"It still remains to be seen whether these individuals can be reinfected and, if so, what that clinical course is like, as T-cell immunity is also an important factor to consider," said Adalja, who wasn't involved in the new study.

T-cells are a distinct component of what's known as the adaptive immune system. They help fight infection in many ways, including directly killing infected cells.

For his part, Creech agreed that just because antibodies to SARS-CoV-2 have a relatively short half-life doesn't mean people lose the ability to fight off recurrent infection.

He explained to the AP that antibodies are proteins produced by immune system B cells to help recognize and destroy cells infected with a virus. When a new virus is first encountered, more generalized forms of antibodies are quickly produced, but their specificity against the virus gets increasingly precise as time goes on.

The B cells also develop a kind of memory as to how to generate these precise antibodies if the virus appears in the body again.

"They would get called into action very quickly when there's a new exposure to the virus. It's as if they lie dormant, just waiting," Creech said. T-cells also lie in wait, able to mount a separate battle against infected cells, he said.

And what about hopes for a vaccine?

Efforts to find an effective vaccine are still valid, Creech said, because a vaccine's highly targeted approach against viruses actually exceeds that of the natural immune system.

"This shouldn't dissuade us from pursuing a vaccine," Creech said. "Antibodies are only a part of the story."

More information

For more on how the immune system works, see the U.S. Library of Medicine.